Surprisingly, during PCR amplification of NMUR2 from the human ovarian cancer cDNA, we identified a dominant splice variant that lacked the third exon, which we have named NMUR2S. Consequently, the encoded sequence is predicted to give rise to a six-transmembrane protein. Here, NMUR2 is linked to ovarian carcinoma.